Literature DB >> 16616749

Fathers over 40 and increased failure to conceive: the lessons of in vitro fertilization in France.

Elise de La Rochebrochard1, Jacques de Mouzon, François Thépot, Patrick Thonneau.   

Abstract

OBJECTIVE: To investigate paternal age effect mediated by biological modifications with use of data from assisted reproductive technologies.
DESIGN: National IVF registry.
SETTING: Fifty nine French IVF centers. PATIENT(S): A total of 1,938 men whose partners were totally sterile, with bilateral tubal obstruction or absence of both tubes (to avoid bias sampling in analysis of paternal age) and treated by conventional IVF. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Risk of failure to conceive defined as absence of intrauterine pregnancy. RESULT(S): The odds ratio of failure to conceive for paternal age > or =40 years was 2.00 (95% confidence interval [CI]: 1.10-3.61) when the woman was 35-37 years old, 2.03 (95% CI: 1.12-3.68) for age 38-40 years, and 5.74 (95% CI: 2.16, 15.23) for age 41 years and over. CONCLUSION(S): As an increasing number of couples choose to postpone childbearing, they should be informed that paternal age over 40 years is an important risk factor for failure to conceive.

Entities:  

Mesh:

Year:  2006        PMID: 16616749     DOI: 10.1016/j.fertnstert.2005.11.040

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  31 in total

Review 1.  Advanced maternal age: are decisions about the timing of child-bearing a failure to understand the risks?

Authors:  Karen M Benzies
Journal:  CMAJ       Date:  2008-01-15       Impact factor: 8.262

2.  Effects of men and recipients' age on the reproductive outcome of an oocyte donation program.

Authors:  Inmaculada Campos; Emilio Gómez; Ana Lucia Fernández-Valencia; José Landeras; Rafaela González; Pilar Coy; Joaquín Gadea
Journal:  J Assist Reprod Genet       Date:  2008-10-07       Impact factor: 3.412

3.  The effect of paternal age on semen quality and fertilization outcome in men with normal sperm DNA compaction, reactive oxygen species, and total antioxidant capacity levels.

Authors:  Sara Darbandi; Mahsa Darbandi; Hamid Reza Khorram Khorshid; Mohammad Reza Sadeghi; Mahnaz Heidari; Ghazaleh Cheshmi; Mohammad Mehdi Akhondi
Journal:  Turk J Urol       Date:  2019-02-05

Review 4.  Advanced paternal age and reproductive outcome.

Authors:  Zofnat Wiener-Megnazi; Ron Auslender; Martha Dirnfeld
Journal:  Asian J Androl       Date:  2011-12-12       Impact factor: 3.285

5.  Functional testicular evaluation using PET/CT with 18F-fluorodeoxyglucose.

Authors:  Lawrence Oliver Dierickx; Eric Huyghe; Daniela Nogueira; Slimane Zerdoud; Thomas Filleron; Séverine Brillouet; Boris Delauney; Jacques Montagut; Louis Bujan; Pierre Plante; Frédéric Courbon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-10       Impact factor: 9.236

6.  Increased human AP endonuclease 1 level confers protection against the paternal age effect in mice.

Authors:  Jamila R Sanchez; Traci L Reddick; Marissa Perez; Victoria E Centonze; Sankar Mitra; Tadahide Izumi; C Alex McMahan; Christi A Walter
Journal:  Mutat Res       Date:  2015-06-20       Impact factor: 2.433

Review 7.  Ageing of the male germ line.

Authors:  Catriona Paul; Bernard Robaire
Journal:  Nat Rev Urol       Date:  2013-02-26       Impact factor: 14.432

Review 8.  Infertility in the Aging Male.

Authors:  Daniel J Mazur; Larry I Lipshultz
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

9.  Combined advanced parental age has an additive negative effect on live birth rates-data from 4057 first IVF/ICSI cycles.

Authors:  Nicole O McPherson; Deirdre Zander-Fox; Andrew D Vincent; Michelle Lane
Journal:  J Assist Reprod Genet       Date:  2017-10-04       Impact factor: 3.412

10.  Male age influences oocyte-donor program results.

Authors:  Eliezer Girsh; Nathan Katz; Leonid Genkin; Ofer Girtler; Jaron Bocker; Sofa Bezdin; Ilya Barr
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.